Loading...
•
Jun 30, 2024
TransMedics Q2 2024 Earnings Report
Achieved record revenue growth driven by OCS NOP and transplant logistics network.
Key Takeaways
TransMedics reported a strong second quarter in 2024, marked by a 118% increase in revenue compared to the previous year. The growth was fueled by the sustained momentum of OCS NOP and the company's transplant logistics network. The company is raising its full year 2024 revenue guidance to be in the range of $425 million to $445 million.
Total revenue reached $114.3 million, a 118% increase compared to Q2 2023.
Net income was $12.2 million, or $0.35 per diluted share.
The company owned 15 total aircraft as of June 30, 2024.
Full year 2024 revenue guidance raised to $425 million to $445 million.
Revenue by Segment
Forward Guidance
TransMedics is raising its full year 2024 revenue guidance to be in the range of $425 million to $445 million, which represents 76% to 84% growth compared to the company’s prior year revenue.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...